Treatment and Management of a Sinonasal Hemangiopericytoma

J Craniofac Surg. 2023 Jul-Aug;34(5):e525-e528. doi: 10.1097/SCS.0000000000009411. Epub 2023 May 23.

Abstract

Sinonasal Hemangiopericytoma (HPC) is a rare vascular tumor originated from Zimmermann's pericyte with not well valuable course. The diagnosis needs a careful ENT endoscopic examination, radiological study and histopathological analysis with immunohistochemistry for confirmation of diagnosis. We describe a case of a male patient, 67 years old, with history of repeated monolateral right epistaxis. Endoscopic and radiological examination showed an ethmoid-sphenoidal lesion which occupied the entire nasal fossa extending towards the choana, with blood supply coming from the posterior ethmoidal artery. The patient performed an extemporaneous biopsy with subsequent en-bloc removal in operating room, without prior embolization, with the Centripetal Endoscopic Sinus Surgery technique (CESS). The histopathologic analysis led to the diagnosis of sinus HPC. The patient performed close endoscopic follow-ups every 2 months, without performing radio or chemotherapy, and with no evidence of recurrence after 3 years of follow-up. Analyzing the recent literature, a more indolent course with low recurrence rates after total endoscopic surgery remotion was described. Preoperative embolization can be useful in determinate cases, but cause to different complications, it should not be ordinarily performed.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Hemangiopericytoma* / diagnostic imaging
  • Hemangiopericytoma* / surgery
  • Humans
  • Male
  • Nasal Cavity / pathology
  • Nose / pathology
  • Nose Neoplasms* / diagnostic imaging
  • Nose Neoplasms* / surgery
  • Paranasal Sinus Neoplasms* / diagnostic imaging
  • Paranasal Sinus Neoplasms* / surgery
  • Solitary Fibrous Tumors*